This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Innovations of Wai-Ming Lee in Antiviral Research
Introduction
Wai-Ming Lee is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of antiviral research, particularly through his innovative patent related to yeast genes that affect viral replication. His work has implications for creating virus-resistant organisms, showcasing the potential of genetic engineering in combating viral infections.
Latest Patents
Wai-Ming Lee holds a patent for an antiviral agent comprising an altered MAB1, MAB2, MAB3, or OLE1 gene, along with gene homologs or related genes. The patent describes a method for creating a virus-resistant organism by developing a transgenic organism that incorporates these antiviral agents. This invention highlights the intersection of genetics and virology, offering new avenues for research and application in disease prevention.
Career Highlights
Wai-Ming Lee is associated with the Wisconsin Alumni Research Foundation, where he continues to advance his research in the field of genetics and virology. His work has garnered attention for its innovative approach to addressing viral replication and resistance.
Collaborations
Wai-Ming Lee has collaborated with esteemed colleagues such as Masayuki Ishikawa and Paul G Ahlquist. These partnerships have contributed to the depth and breadth of his research, fostering a collaborative environment that enhances scientific discovery.
Conclusion
Wai-Ming Lee's contributions to antiviral research through his innovative patent demonstrate the potential of genetic engineering in developing solutions for viral infections. His work continues to inspire advancements in the field and highlights the importance of collaboration in scientific research.